Omitting radiation and giving fewer chemotherapy treatments may become the new standard of care for patients with diffuse large B-cell lymphoma (DLBCL) classified as either stage 1 or 2, according to the findings of the S1001 study led by a University of Arizona Health Sciences researcher.

ENR Southwest’s 2020 Best Projects competition drew 74 entries from across Arizona, Nevada and New Mexico. The University of Arizona Health Sciences Innovation Building (HSIB) was selected in the Best Project category. The region’s 18 Best Projects will now advance to the national level, competing with winners from nine other regions to be considered for ENR’s Best of the Best awards.

Continuing coverage: Ginny L. Clements, a breast cancer survivor and longtime supporter of the University of Arizona has given $8.5 million to the University of Arizona Cancer Center to strengthen the center's breast cancer patient care and research programs.

Rubin Naiman, Ph.D., of the University of Arizona Center for Integrative Medicine shares a tip on how to get a good night’s sleep. “If you can’t get back to sleep in the middle of the night, try to remember a dream. We’re programmed for wakefulness—the state of awareness during the day. Recalling a dream helps you let go of this daytime consciousness. The memory of a dream will take you into dream consciousness, and then you’re on the bridge to sleep,” he says.

Experts in the Comprehensive Pain and Addiction Center are tackling the diverse yet related issues of substance misuse, chronic pain and addiction.

The Mel and Enid Zuckerman College of Public Health turns 20 this year, find out who has worked at the college the entire time.

The College of Public Health honors its ‘MEZCOPH Originals,’ faculty and staff who have been with the college since its inception in 2000.

Health professionals trained to work together can give children with severe pulmonary diseases better, more holistic care.

Continuing coverage: A recent study led by University of Arizona Health Sciences researchers found that COVID-19 antibodies can last between five and seven months after recovery. However, contradictory research suggests that they fade within weeks.